v3.25.2
Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning Balance at Dec. 31, 2023 $ 3,580     $ 41,466 $ (37,886)
Beginning Balance (Shares) at Dec. 31, 2023     86,241    
Issuance of common stock for restricted stock award (in shares)     441    
Stock-based compensation expense 54     54  
Net loss (1,481)       (1,481)
Ending Balance at Mar. 31, 2024 2,153     41,520 (39,367)
Ending Balance (Shares) at Mar. 31, 2024     86,682    
Beginning Balance at Dec. 31, 2023 3,580     41,466 (37,886)
Beginning Balance (Shares) at Dec. 31, 2023     86,241    
Net loss (2,747)        
Ending Balance at Jun. 30, 2024 4,192   $ 1 44,824 (40,633)
Ending Balance (Shares) at Jun. 30, 2024     363,741    
Beginning Balance at Mar. 31, 2024 2,153     41,520 (39,367)
Beginning Balance (Shares) at Mar. 31, 2024     86,682    
Issuance of common stock and warrants, net of issuance costs and warrants issued to placement agents 3,181   $ 1 3,180  
Issuance of common stock and warrants, net of issuance costs and warrants issued to placement agents, (in shares)     277,059    
Issuance of warrants 70     70  
Stock-based compensation expense 54     54  
Net loss (1,266)       (1,266)
Ending Balance at Jun. 30, 2024 4,192   $ 1 44,824 (40,633)
Ending Balance (Shares) at Jun. 30, 2024     363,741    
Beginning Balance at Dec. 31, 2024 2,535   $ 1 46,075 (43,541)
Beginning Balance (Shares) at Dec. 31, 2024     556,902    
Issuance of stock for consideration of licensed technology 1,700     1,700  
Issuance of stock for consideration of licensed technology (Shares)   491 111,339    
Issuance of common stock for equity line of credit 94     94  
Issuance of common stock for equity line of credit (Shares)     29,800    
Issuance of common stock in lieu of fractional shares for stock split (In shares)     76    
Issuance of warrants 109     109  
Exercise of warrants (Shares)     7,524    
Stock-based compensation expense 100     100  
Net loss (1,502)       (1,502)
Ending Balance at Mar. 31, 2025 3,036   $ 1 48,078 (45,043)
Ending Balance (Shares) at Mar. 31, 2025   491 705,641    
Beginning Balance at Dec. 31, 2024 2,535   $ 1 46,075 (43,541)
Beginning Balance (Shares) at Dec. 31, 2024     556,902    
Net loss (3,433)        
Ending Balance at Jun. 30, 2025 3,687   $ 1 50,661 (46,975)
Ending Balance (Shares) at Jun. 30, 2025   1,191 965,899    
Beginning Balance at Mar. 31, 2025 3,036   $ 1 48,078 (45,043)
Beginning Balance (Shares) at Mar. 31, 2025   491 705,641    
Issuance of common stock, net of issuance costs 1,908     1,908  
Issuance of common stock, net of issuance costs (in shares)     260,258    
Issuance of preferred stock and common stock warrants, net of issuance costs and warrants to placement agents (in shares)   700      
Issuance of preferred stock and common stock warrants, net of issuance costs and warrants to placement agents 549     549  
Issuance of warrants 36     36  
Stock-based compensation expense 90     90  
Dividends declared on Series B preferred stock (1)       (1)
Net loss (1,931)       (1,931)
Ending Balance at Jun. 30, 2025 $ 3,687   $ 1 $ 50,661 $ (46,975)
Ending Balance (Shares) at Jun. 30, 2025   1,191 965,899